Biofrontera Inc. Announces Data Base Locks for Two Clinical Studies Supporting Key Data and Regulatory Milestones

Database locks for studies on actinic keratosis (AK) and acne vulgaris achieved on January 5, 2026Data generated will support key regulatory ...
Nasdaq

Incannex achieves key milestone with database lock for RePOSA Phase 2 trial of IHL-42X

NEW YORK and MELBOURNE, Australia, June 18, 2025 (GLOBE NEWSWIRE) -- Incannex Healthcare Inc. (Nasdaq: IXHL) (“Incannex” or the “Company”), a clinical-stage biopharmaceutical company advancing ...
Seeking Alpha

OncoSec Announces Clinical Data of the KEYNOTE-695 Trial Assessing TAVO™-EP in Combination with KEYTRUDA® (pembrolizumab) in Patients with Advanced Melanoma Refractory to ...

EWING, N.J. and SAN DIEGO, April 3, 2023 /PRNewswire/ -- OncoSec Medical Incorporated (ONCS) (the Company or OncoSec), a clinical-stage biotechnology company developing intratumoral immunotherapies to ...
Khaleej Times on MSN

Reem Hospital successfully completes its inaugural Alzheimer's disease clinical trial

Reem Hospital has announced the successful completion and database lock of its clinical trial, the TauRx TRx-237-805 study, a ...